Literature DB >> 8208343

Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11p and 17p in medulloblastomas.

S Albrecht1, A von Deimling, T Pietsch, F Giangaspero, S Brandner, P Kleihues, O D Wiestler.   

Abstract

Medulloblastoma (MB) is a primitive neuroectodermal tumour of the cerebellum whose pathogenesis is poorly understood. Previous studies suggest a role for loci on chromosomes 11p and 17p in the pathogenesis of MB. Evidence for another potential MB locus has recently emerged from studies on Gorlin syndrome (GS), an autosomal dominant syndrome with multiple basal cell carcinomas, epithelial jaw cysts, and skeletal anomalies. Since GS can be associated with MB, we examined sporadic (non-GS) cases of MB for evidence of loss of heterozygosity (LOH) on chromosome 9 where a putative GS locus has been localized to band q31. Nineteen paired blood and MB DNA specimens from 16 patients (11 primary tumours, two primary with recurrent tumours, one primary tumour and cell line, two cell lines) were studied by PCR analysis of microsatellites at D9S55 (9p12), D9S15 (9q13-q21.1), D9S127 (9q21.1-21.3), D9S12 (9q22.3), D9S58 (9q22.3-q31), D9S109 (9q31), D9S53 (9q31), GSN (9q33), D9S60 (9q33-q34), D9S65 (9q33-q34), ASS (9q34), D9S67 (9q34.3), TH (11p15.5), D11S490 (11q23.3), D17S261 (17p11.2-12), D17S520 (17p12), TP53 (17p13.1), D17S5 (17p13.3), D17S515 (17q22-qter), and by RFLP analysis at the WT-1 locus (11p13). Only two tumours had LOH on 9q. One was non-informative at D9S15, D9S65, and GSN but showed LOH at D9S127, D9S12, D9S58, D9S109, D9S53, D9S60, ASS, and D9S67. The other was uninterpretable at D9S65 and non-informative at D9S15, D9S58, D9S53, and D9S67 but exhibited LOH at D9S127, D9S12, D9S109, GSN, D9S60, and ASS. Both these cases were informative at D9S55 without LOH.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8208343     DOI: 10.1111/j.1365-2990.1994.tb00959.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  8 in total

1.  Molecular genetic studies of chromosome 11 and chromosome 22q DNA sequences in pediatric medulloblastomas.

Authors:  S Lescop; A Lellouch-Tubiana; G Vassal; C Besnard-Guerin
Journal:  J Neurooncol       Date:  1999-09       Impact factor: 4.130

Review 2.  Medulloblastoma: molecular genetics and animal models.

Authors:  Corey Raffel
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

3.  Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas.

Authors:  D Schofield; D C West; D C Anthony; R Marshal; J Sklar
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

4.  Detection of frameshift mutations of RIZ in gastric cancers with microsatellite instability.

Authors:  Kai-Feng Pan; You-Yong Lu; Wan-Guo Liu; Lian Zhang; Wei-Cheng You
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

5.  The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma.

Authors:  R Cowan; P Hoban; A Kelsey; J M Birch; R Gattamaneni; D G Evans
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system.

Authors:  A S Y W Burns; E Jaros; M Cole; R Perry; A J Pearson; J Lunec
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

7.  Transcriptional map of 170-kb region at chromosome 11p15.5: identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples.

Authors:  C Schwienbacher; S Sabbioni; M Campi; A Veronese; G Bernardi; A Menegatti; I Hatada; T Mukai; H Ohashi; G Barbanti-Brodano; C M Croce; M Negrini
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

8.  High resolution chromosome 3p, 8p, 9q and 22q allelotyping analysis in the pathogenesis of gallbladder carcinoma.

Authors:  I I Wistuba; A Maitra; R Carrasco; M Tang; P Troncoso; J D Minna; A F Gazdar
Journal:  Br J Cancer       Date:  2002-08-12       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.